Publication | Closed Access

Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation

InflammationNf-e2-related Factor 2Cardiovascular DiseaseAtherosclerosisMedicineVascular AdaptationEndothelial DysfunctionGemigliptin PreventsDipeptidyl Peptidase-4 InhibitionVascular BiologyMicrovascular DysfunctionPharmacologyCell BiologyCell Signaling